Vimarsana
Biggest News Aggregation in the World

Page 48 - Research Square News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Research Square. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Research Square Today - Breaking & Trending Today

The frequency and nature of RNA errors in both SARS-CoV-2 and its vaccine - Vimarsana News

The frequency and nature of RNA errors in both SARS-CoV-2 and its vaccine

A recent article demonstrated that SARS-CoV-2 mutants and vaccine variability stem from ribonucleic acid polymerase inaccuracy.

Pfizer's Paxlovid reduces Covid-19 risk in seniors regardless of vaccine status: Study - Vimarsana News

Pfizer's Paxlovid reduces Covid-19 risk in seniors regardless of vaccine status: Study

JERUSALEM - Pfizer Inc's antiviral treatment Paxlovid reduces Covid-19 hospitalisation and death rates in vaccinated and unvaccinated patients 65 years and older, according to a new study in Israel conducted during the rise of the Omicron variant of the coronavirus. The treatment, however, was not found to prevent severe illness among younger adults, according to research from Clalit Health Services,...

Study: Pfizer's Paxlovid reduces Covid risk in seniors regardless of vaccine status - Vimarsana News

Study: Pfizer's Paxlovid reduces Covid risk in seniors regardless of vaccine status

JERUSALEM, June 3 — Pfizer Inc’s PFE.N antiviral treatment Paxlovid reduces Covid-19 hospitalisation and death rates in vaccinated and unvaccinated patients 65 years and older,...

NBMA tasks Nigerians on safety measures against Monkeypox - Vimarsana News

NBMA tasks Nigerians on safety measures against Monkeypox

National Biosafety Management Agency (NBMA) has charged Nigerians with proactive measures to check the spread of Monkeypox in the country.

Paxlovid reduces COVID risk in vaxxed and unvaxxed seniors - study - Vimarsana News

Paxlovid reduces COVID risk in vaxxed and unvaxxed seniors - study

Use of Pfizer's pills, authorized to treat newly infected, at-risk people in order to prevent severe illness, has soared in the United States.

Source: jpost.com